Estrogen Receptor Status - Clinical Trial Eligibility Criteria

Known as: ER Status, Estrogen Receptor Status 
The estrogen receptor level measured in a primary tumor or in metastases. There are essentially two distinct forms of breast cancer, one that tends… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
BACKGROUND AND OBJECTIVE Sentinel lymph node dissection (SLND) has eliminated the need for axillary dissection (ALND) in patients… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
UNLABELLED PURPOSE To improve on current standards for breast cancer prognosis and prediction of chemotherapy benefit by… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Validating prognostic or predictive candidate genes in appropriately powered breast cancer cohorts are of utmost interest. Our… (More)
  • figure 1
  • figure 2
  • table 2
  • table 3
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Molecular classification of breast cancer has been proposed based on gene expression profiles of human tumors. Luminal… (More)
  • figure 1
  • table 2
  • table 3
  • figure 2
  • table 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE To determine whether progesterone receptor (PgR) status provides additional value to estrogen receptor (ER) status and… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Prognostic and predictive factors are indispensable tools in the treatment of patients with neoplastic disease. For the most part… (More)
  • table 1
Is this relevant?
Highly Cited
2001
Highly Cited
2001
To investigate the phenotype associated with estrogen receptor alpha (ER) expression in breast carcinoma, gene expression… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
PURPOSE Immunohistochemistry (IHC) is a newer technique for assessing the estrogen receptor (ER) status of breast cancers, with… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
1997
Review
1997
The skeleton is the most common organ to be affected by metastatic cancer, and tumors arising from the breast, prostate, thyroid… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
BACKGROUND The B-20 study of the National Surgical Adjuvant Breast and Bowel Project (NSABP) was conducted to determine whether… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?